We’re not the only ones that will need a caffeine hit tomorrow… (Picture: Metro/Greggs/Getty) Metro journalists select and curate the products that feature on our site. If you make a purchase via ...

Marina is that curiosity, a cult female star making pop music. Unlike most female pop stars of her longevity, she’s never had one of those monster hits that everyone knows. She has no “Poker Face”, ...

Cogent Biosciences (COGT) is poised for two product launches later this year after the FDA granted priority review for its marketing application for its lead candidate, bezuclastini, for a rare form ...

May 21 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday that the U.S. Food ⁠and Drug Administration had accepted its supplemental New Drug Application for finerenone and granted priority ...

The sNDA for sevabertinib is supported by data from the SOHO-01 trial, showing a median duration of response of 11.0 months and a 71% objective response rate in patients with HER2-mutated NSCLC who ...

New funding will examine more than fifteen years of reports to identify missed opportunities to protect women. The work follows fresh national concerns over domestic abuse related deaths. 'He's in my ...

ISLANDIA, N.Y.--(BUSINESS WIRE)--O2 Investment Partners (www.o2investment.com) announced today that it has partnered with Atlas Asphalt (“Atlas” or the “Company ...

Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease priority review voucher (PRV), striking a $180 million sale that reflects the high market demand for a speedy FDA review.

The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest ...

The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. Limited time: Save 25% on ...